跳至主要内容
临床试验/CTRI/2019/11/022040
CTRI/2019/11/022040尚未招募4 期

"Study the effect of Nitya Virechana with Trivrit and Aragvadha Churna in the management of Stage 1 Essential Hypertension"

Dr Manju Mohan1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年11月21日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Reduce in the symptoms and range of Blood pressure

研究概览

简要总结

Patients will be recruited from inclusion criteria and study the effect of  Trivrit and Aragvadha Churna Nitya virechana in Stage 1 Essential Hypertension

To study the effect of Nitya virechana with Trivrit Churna on systolic and diastolic blood pressure.

To study the effect of Nitya virechana with Aragvadha Churna on systolic and diastolic blood pressure

To compare the effect of Nitya virechana with Trivrit and Aragvadha churna on systolic and diastolic blood pressure.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients of either sex between the age group of 30-60 yrs will be selected.
  • 2.Newly detected cases of Stage 1 Essential Hypertension will be selected.

排除标准

  • 1.Hypertension associated with: a.Cardio-vascular diseases b.Cerebro-vascular diseases c.Hypothyroidism d.Diabetes Mellitus (Type 1/ Type 2/ GDM) e.Pregnant and lactating women.

结局指标

主要结局

Reduce in the symptoms and range of Blood pressure

时间窗: Six months

次要结局

  • 1.To study the effect of Nitya Virechana with Trivrit Churna on Systolic and Diastolic blood pressure.(2.To study the effect of Nitya Virechana with Aragvadha Churna on Systolic and Diastolic blood pressure.)

研究者

发起方
Dr Manju Mohan
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验